IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer
IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer
Recruiting · NCT05551507 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Recruiting | Phase 1 / Phase 2 | 2026-05-04 | NCT05551507 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InxMed (Shanghai) Co., Ltd. | 10 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Obstetrics and Gynecology Hospital of Zhejiang University | Hangzhou | China | 1 |
| Anyang Cancer Hospital | Anyang | China | 4 |
| Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College | Beijing | China | 1 |
| Fujian Cancer Hospital | Fuzhou | China | 37 |
| Henan Cancer Hospital | Zhengzhou | China | 60 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Tianjin Cancer Hospital | Tianjin | China | 10 |